Articles |
 Page 1 of 2  |
Insmed restructures, eliminates positions.(Brief Article)
September 30, 2002
|
Georgia to increase biotech development.(Brief Article)
September 30, 2002
|
Aureon discloses $15m round for diagnostics.(Aureon Biosciences)(Brief...
September 30, 2002
|
OGS separating business into three units.(Oxford GlycoSciences)(Brief ...
September 30, 2002
|
Genome Therapeutics to reduce staff, spending.(Brief Article)
September 30, 2002
|
Phytobiotech raises C$17m in second round.(Brief Article)
September 30, 2002
|
Bush administration nominates McClellan.(George W. Bush, Mark McClella...
September 30, 2002
|
StemCells cutting back to focus on diseases.(Brief Article)
September 30, 2002
|
Modex, IsoTis plan to merge programs.(Modex Therapeutics)(Brief Articl...
September 30, 2002
|
Kosan signs $220m deal with Roche for KOS-862.(Kosan Biosciences Inc.)...
September 30, 2002
|
Gilead's Hepsera approved for hepatitis B.(Gilead Sciences Inc.)
September 30, 2002
|
Genmab stopping trials of HuMax-CD4 in RA.(Brief Article)
September 30, 2002
|
Aviva raises $11.8m to push biochip technology.(Aviva Biosciences Corp...
September 30, 2002
|
Pharmagenesis, Fujisawa enter research deal.(Brief Article)
September 30, 2002
|
Zaffaroni starts another firm; Alexza raises $45m.(Alex Zaffaroni )(Br...
September 30, 2002
|
Indevus' trospium Phase III hits endpoints.(Indevus Pharmaceuticals In...
September 30, 2002
|
FDA panel backs EGFR drug from AstraZeneca.(United States. Food and Dr...
September 30, 2002
|
CellGate closes $10m Series D financing.(Brief Article)
September 30, 2002
|
Bio-Technology General to acquire Rosemont.(Rosemont Pharmaceuticals L...
September 30, 2002
|
CombinatoRx raises $40m, prepares to enter clinic.(Brief Article)
September 30, 2002
|
Panel advises firms in deal-making strategies.(Brief Article)
September 30, 2002
|
eXegenics, IDDS merging via $46m stock deal.(Innovative Drug Delivery ...
September 30, 2002
|
Cyclopamine plant blockaded childhood brain cancer. (News from the Lab...
September 30, 2002
|
Amylin's persistence pays off with $435m Lilly deal.(Amylin Pharmaceut...
September 30, 2002
|
Therapeutic-not human-cloning OK, scientists report. (News From the La...
September 23, 2002
|
Genetech, XOMA produce strong Phase III data.(Brief Article)
September 23, 2002
|
IDEC collaborates with Caprion on proteomics.(Brief Article)
September 23, 2002
|
Trimeris, Roche submit NDA for Fuzeon approval.(Brief Article)
September 23, 2002
|
Ariad's technology shows promise in animals.(Ariad Pharmaceuticals Inc...
September 23, 2002
|
FDA accepts Genzyme, BioMarin's BLA.(Brief Article)
September 23, 2002
|
Millennium's Crohn's drug fails in phase II.(Brief Article)
September 23, 2002
|
ARC parlays deals into polymeric platform.(Brief Article)
September 23, 2002
|
FDA: Amevive review will be done in 6 months.(Brief Article)
September 23, 2002
|
GenStar, Vascular Genetics to form Autus.(Brief Article)
September 23, 2002
|
Endovasc subsidiaries for two products formed.(Liprostin Development C...
September 23, 2002
|
Positive results from Gliadel trial follow-up.(Guilford Pharmaceutical...
September 23, 2002
|
ISTA secures $40m as it nears Vitrase NDA filing.(ISTA Pharmaceuticals...
September 23, 2002
|
Biomira, Mmerck miss early theratope endpoints.(Brief Article)
September 23, 2002
|
CuraGen, Bayer complete work in Toxicogenomics.(Brief Article)
September 23, 2002
|
Nephros raises $17M for acute renal failure device.(Nephros Therapeuti...
September 23, 2002
|
Novacea, Aventis move calcitriol into phase II/III.(Brief Article)
September 23, 2002
|
'Painfully slow' road ahead for genomics.(Brief Article)
September 23, 2002
|
Vical abandons studies, including phase III.(Allovectin-7)(Brief Artic...
September 23, 2002
|
Onyx regains remainder of rights to ONYX-015.(Brief Article)
September 23, 2002
|
LION cutting back on drug discovery.(LION bioscience AG)(Brief Article...
September 16, 2002
|
House considers employee stock options.(Brief Article)
September 16, 2002
|
FDA plan could lead to faster review times.(United States. Food and Dr...
September 16, 2002
|
Human Genome may improve disease management. (News From the Lab).(Brie...
September 16, 2002
|
Genentech's Avastin misses in breast cancer Phase III.(Brief Article)
September 16, 2002
|
Micrologix buys Origenix, gets antisense assets.(Micrologix Biotech In...
September 16, 2002
|
Lawmakers discuss stricter patient consent.(Deborah Peel, American Psy...
September 16, 2002
|
Telik aims to sell 5M shares, plans Phase III.(finance and TLK286 rese...
September 16, 2002
|
Peoples Genetics searches for gene mutations.(biotechnology industry, ...
September 16, 2002
|
Signase plans growth on Src kinase family platform.(protein tyrosine k...
September 16, 2002
|
Gilead returns Cidecin rights in Europe.(Gilead Sciences Inc. ends lic...
September 16, 2002
|
Dyax cuts staff to advance lead products.(finance)(Brief Article)(Stat...
September 16, 2002
|
Insmed reports failed Phase II in diabetes.(INS-1 research)(Brief Arti...
September 16, 2002
|
Cellegy resurrects Cellegesic, plans phase III.(Cellegy Pharmaceutical...
September 16, 2002
|
Immune Response cuts staff to focus on remune.(Brief Article)
September 16, 2002
|
European biotechnology struggling, leaders say.(Brief Article)
September 16, 2002
|
Verdict favors Genentech in Chiron's Herceptin suit.(Brief Article)
September 16, 2002
|
IDEC views psoriasis data, drops indication.(IDEC Pharmaceuticals Corp...
September 09, 2002
|
SignalGene spins off Alethia Bio Therapeutics.(Alethia Bio Therapeutic...
September 09, 2002
|
Versicor reports positive Phase II dalbavancin data.(antibiotic trials...
September 09, 2002
|
Genelabs gets lupus drug approvable letter.(Prestara )(Brief Article)
September 09, 2002
|
Gene therapy pulled hamsters back from brink. (News from the Lab).(hea...
September 09, 2002
|
Generics, biotech groups position for fight.(drug patent legislation)(...
September 09, 2002
|
Aventis declines alliance on Indevus' pagoclone.(Indevus Pharmaceutica...
September 09, 2002
|
Sequenom completes Axiom purchase.(Axiom Biotechnologies)(Brief Articl...
September 09, 2002
|
With RSD123S data, Cardiome seeks partners.(Cardiome Pharma Corp. trea...
September 09, 2002
|
Aradigm, Novo Nordisk begin NN1998 Phase III.(inhaled insulin Diabetes...
September 09, 2002
|
Cellomics financing gets $15m for genomics.(Carl Zeiss Jena GmbH lead ...
September 09, 2002
|
Enanta, Chiron collaborate on HCV therapeutics.(hepatitis C virus)(Bri...
September 09, 2002
|
Alcon's phase III tests AMD treatment.(Alcon Research Ltd. tests Aneco...
September 09, 2002
|
DNA Sciences, Merck in genetic variant deal.(Brief Article)
September 09, 2002
|
| More
articles from BioWorld Week... |
